NewsBenzingaAkebia Therapeutics presenta datos del estudio de experiencia en centros sobre resultados con Vafseo en la Semana del Riñón 2026 de la Sociedad Americana de Nefrología en pacientes tratados con vadadustat Akebia Therapeutics presenta datos del estudio de experiencia en centros sobre resultados con Vafseo en la Semana del Riñón 2026 de la Sociedad Americana de Nefrología en pacientes tratados con vadadustat Benzinga 2026.10.26 13:24 (GMT+0) Open on Benzinga Other news AI models can be tricked into identifying civilians as military targets by telling them it’s a game Why Nvidia Is Falling Tuesday: Jensen Huang’s Comeback Statement, Congress Hearings, and AI Risks General Motors Plans 20% Boost In Robotics As Factory Costs Rise Eli Lilly Inks Multibillion-Dollar Pact to Develop Precision Cancer Therapies McKesson Stock Is a Triple Threat at New All-Time Highs. How to Trade It Here. 'Nvidia stopped disclosing Singapore sales as revenues hit $104B' -FT